
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Convergent somatic evolution commences in utero in a germline ribosomopathy
Heather E. Machado, Nina Friesgaard Ă˜bro, Nicholas Williams, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Heather E. Machado, Nina Friesgaard Ă˜bro, Nicholas Williams, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Ribosome specialization by cancer-associated ribosomal protein mutations: progress made and open questions
Marino Caruso, Kim De Keersmaecker
Philosophical Transactions of the Royal Society B Biological Sciences (2025) Vol. 380, Iss. 1921
Closed Access
Marino Caruso, Kim De Keersmaecker
Philosophical Transactions of the Royal Society B Biological Sciences (2025) Vol. 380, Iss. 1921
Closed Access
Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia
Aleksandra E Kamizela, Daniel Leongamornlert, Nicholas Williams, et al.
Nature (2025)
Open Access
Aleksandra E Kamizela, Daniel Leongamornlert, Nicholas Williams, et al.
Nature (2025)
Open Access
Mechanistic insights into the developmental origin of pediatric hematologic disorders
Giuseppina Camiolo, Christopher Mullen, Katrin Ottersbach
Experimental Hematology (2024) Vol. 136, pp. 104583-104583
Open Access | Times Cited: 2
Giuseppina Camiolo, Christopher Mullen, Katrin Ottersbach
Experimental Hematology (2024) Vol. 136, pp. 104583-104583
Open Access | Times Cited: 2
Azacitidine combined with venetoclax alleviates AML-MR with TP53 mutation in SDS: a case report and literature review
MA Cui-ping, Haiyan Lang, Yuhan Chen, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 1
MA Cui-ping, Haiyan Lang, Yuhan Chen, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 1
Emerging genetic technologies informing personalized medicine in SDS and other inherited bone marrow failure disorders
Alyssa Cull, David G. Kent, Alan J. Warren
Blood (2024) Vol. 144, Iss. 9, pp. 931-939
Closed Access | Times Cited: 1
Alyssa Cull, David G. Kent, Alan J. Warren
Blood (2024) Vol. 144, Iss. 9, pp. 931-939
Closed Access | Times Cited: 1
Ribosome abundance, not paralogue composition, is essential for germline development
Katarina Z.A. Grobicki, Daniel Gebert, Changfeng Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Katarina Z.A. Grobicki, Daniel Gebert, Changfeng Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clonal hematopoiesis in cancer predisposition syndromes
Kenichi Yoshida
International Journal of Hematology (2024)
Closed Access
Kenichi Yoshida
International Journal of Hematology (2024)
Closed Access